Abstract
Background: Both parametric and nonparametric methods have been proposed to support model-informed precision dosing (MIPD). However, which approach leads to better models remains uncertain. Using open-source software, these 2 statistical approaches for model development were compared using the pharmacokinetics of vancomycin in a challenging subpopulation of class 3 obesity.
Methods: Patients on vancomycin at the University of Vermont Medical Center from November 1, 2021, to February 14, 2023, were entered into the MIPD software. The inclusion criteria were body mass index (BMI) of at least 40 kg/m2 and 1 or more vancomycin levels. A parametric model was created using nlmixr2/NONMEM, and a nonparametric model was created using Pmetrics. Then, a priori and a posteriori predictions were evaluated using the normalized root mean squared error (nRMSE) for precision and the mean percentage error (MPE) for bias. The parametric model was evaluated in a simulated MIPD context using an external validation dataset.
Results: In total, 83 patients were included in the model development, with a median age of 56.6 years (range: 24–89 years), and a median BMI of 46.3 kg/m2 (range: 40–70.3 kg/m2). Both parametric and nonparametric models were 2-compartmental, with creatinine clearance and fat-free mass as covariates to clearance and volume parameters, respectively. The a priori MPE and nRMSE for the parametric versus nonparametric models were −6.3% versus 2.69% and 27.2% versus 30.7%, respectively. The a posteriori MPE and RMSE were 0.16% and 0.84%, and 13.8% and 13.1%. The parametric model matched or outperformed previously published models on an external validation dataset (n = 576 patients).
Conclusion: Minimal differences were found in the model structure and predictive error between the parametric and nonparametric approaches for modeling vancomycin class 3 obesity. However, the parametric model outperformed several other models, suggesting that institution-specific models may improve pharmacokinetics management.
Hughes, Maria-Stephanie A. PharmD*; Hughes, Jasmine H. PhD*; Endicott, Jeffrey PharmD†; Langton, Meagan PharmD†; Ahern, John W. PharmD†; Keizer, Ron J. PharmD, PhD*. Developing Parametric and Nonparametric Models for Model-Informed Precision Dosing: A Quality Improvement Effort in Vancomycin for Patients With Obesity. Therapeutic Drug Monitoring ():10.1097/FTD.0000000000001214, May 10, 2024. | DOI: 10.1097/FTD.0000000000001214 https://journals.lww.com/drug-monitoring/fulltext/9900/developing_parametric_and_nonparametric_models_for.223.aspx